TrialsgrambetaRCTs are beautiful

Webster Cabergoline Trial

1994

Cabergoline versus Bromocriptine in Hyperprolactinaemic Amenorrhoea

In 459 women with hyperprolactinaemic amenorrhoea, cabergoline 0.5–1.0 mg twice weekly achieved stable normoprolactinaemia, ovulation and pregnancy more often than bromocriptine.

Result

Stable normoprolactinaemia
Absolute difference
24 points
NNT
5

Absolute difference and NNT are derived from the event rates.

Also reported: Ovulation/pregnancy 72 % vs 52 %; better tolerability.

Original publication
Subtopic
Prolactinoma
Design
Double-blind RCT
Relevance
Supporting: context rather than must-know.
Source
Webster J, et al. N Engl J Med. 1994;331(14):904-909.doi 10.1056/NEJM199410063311403

Discussion & critique

Established cabergoline as first-line therapy for prolactinoma, a position unchanged for three decades.